At the 2025 North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN), held in Chicago, Illinois, investigators presented new interim safety findings from the phase 3 R-ALLY trial and its open-label extension…
Safety, tolerability of tenapanor in pediatric IBS-C patients, with Thomas Wallach, MD
